24848988|t|PKCepsilon promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Abeta degradation in brain neurons.
24848988|a|Amyloid-beta (Abeta) peptide accumulation in the brain is a pathological hallmark of all forms of Alzheimer's disease. An imbalance between Abeta production and clearance from the brain may contribute to accumulation of neurotoxic Abeta and subsequent synaptic loss, which is the strongest correlate of the extent of memory loss in AD. The activity of neprilysin (NEP), a potent Abeta-degrading enzyme, is decreased in the AD brain. Expression of HuD, an mRNA-binding protein important for synaptogenesis and neuronal plasticity, is also decreased in the AD brain. HuD is regulated by protein kinase Cepsilon (PKCepsilon), and we previously demonstrated that PKCepsilon activation decreases Abeta levels. We hypothesized that PKCepsilon acts through HuD to stabilize NEP mRNA, modulate its localization, and support NEP activity. Conversely, loss of PKCepsilon-activated HuD in AD leads to decreased NEP activity and accumulation of Abeta. Here we show that HuD is associated with NEP mRNA in cultures of human SK-N-SH cells. Treatment with bryostatin, a PKCepsilon-selective activator, enhanced NEP association with HuD and increased NEP mRNA stability. Activation of PKCepsilon also increased NEP protein levels, increased NEP phosphorylation, and induced cell surface expression. In addition, specific PKCepsilon activation directly stimulated NEP activity, leading to degradation of a monomeric form of Abeta peptide and decreased Abeta neuronal toxicity, as measured by cell viability. Bryostatin treatment also rescued Abeta-mediated inhibition of HuD-NEP mRNA binding, NEP protein expression, and NEP cell membrane translocation. These results suggest that PKCepsilon activation reduces Abeta by up-regulating, via the mRNA-binding protein HuD, Abeta-degrading enzymes such as NEP. Thus, PKCepsilon activation may have therapeutic efficacy for AD by reducing neurotoxic Abeta accumulation as well as having direct anti-apoptotic and synaptogenic effects. 
24848988	0	10	PKCepsilon	Gene	5581
24848988	33	43	neprilysin	Gene	4311
24848988	72	82	neprilysin	Gene	4311
24848988	91	96	Abeta	Gene	351
24848988	127	139	Amyloid-beta	Gene	351
24848988	141	146	Abeta	Gene	351
24848988	225	244	Alzheimer's disease	Disease	MESH:D000544
24848988	267	272	Abeta	Gene	351
24848988	347	357	neurotoxic	Disease	MESH:D020258
24848988	358	363	Abeta	Gene	351
24848988	379	392	synaptic loss	Disease	MESH:D012183
24848988	444	455	memory loss	Disease	MESH:D008569
24848988	459	461	AD	Disease	MESH:D000544
24848988	479	489	neprilysin	Gene	4311
24848988	491	494	NEP	Gene	4311
24848988	506	511	Abeta	Gene	351
24848988	550	552	AD	Disease	MESH:D000544
24848988	682	684	AD	Disease	MESH:D000544
24848988	692	695	HuD	Disease	
24848988	737	747	PKCepsilon	Gene	5581
24848988	786	796	PKCepsilon	Gene	5581
24848988	818	823	Abeta	Gene	351
24848988	853	863	PKCepsilon	Gene	5581
24848988	894	897	NEP	Gene	4311
24848988	943	946	NEP	Gene	4311
24848988	977	987	PKCepsilon	Gene	5581
24848988	1005	1007	AD	Disease	MESH:D000544
24848988	1027	1030	NEP	Gene	4311
24848988	1060	1065	Abeta	Gene	351
24848988	1108	1111	NEP	Gene	4311
24848988	1132	1137	human	Species	9606
24848988	1138	1145	SK-N-SH	CellLine	CVCL:0531
24848988	1168	1178	bryostatin	Chemical	MESH:D054713
24848988	1182	1192	PKCepsilon	Gene	5581
24848988	1223	1226	NEP	Gene	4311
24848988	1262	1265	NEP	Gene	4311
24848988	1296	1306	PKCepsilon	Gene	5581
24848988	1322	1325	NEP	Gene	4311
24848988	1352	1355	NEP	Gene	4311
24848988	1432	1442	PKCepsilon	Gene	5581
24848988	1474	1477	NEP	Gene	4311
24848988	1534	1539	Abeta	Gene	351
24848988	1562	1567	Abeta	Gene	351
24848988	1568	1585	neuronal toxicity	Disease	MESH:D009410
24848988	1618	1628	Bryostatin	Chemical	MESH:D054713
24848988	1652	1657	Abeta	Gene	351
24848988	1685	1688	NEP	Gene	4311
24848988	1703	1706	NEP	Gene	4311
24848988	1731	1734	NEP	Gene	4311
24848988	1791	1801	PKCepsilon	Gene	5581
24848988	1821	1826	Abeta	Gene	351
24848988	1879	1884	Abeta	Gene	351
24848988	1911	1914	NEP	Gene	4311
24848988	1922	1932	PKCepsilon	Gene	5581
24848988	1978	1980	AD	Disease	MESH:D000544
24848988	1993	2003	neurotoxic	Disease	MESH:D020258
24848988	2004	2009	Abeta	Gene	351
24848988	Association	MESH:D000544	351
24848988	Positive_Correlation	MESH:D009410	351
24848988	Negative_Correlation	MESH:D054713	351
24848988	Negative_Correlation	351	4311
24848988	Association	MESH:D008569	351
24848988	Positive_Correlation	4311	5581
24848988	Positive_Correlation	MESH:D054713	4311
24848988	Negative_Correlation	MESH:D009410	5581
24848988	Positive_Correlation	MESH:D054713	5581
24848988	Negative_Correlation	351	5581
24848988	Association	MESH:D020258	351
24848988	Negative_Correlation	MESH:D000544	4311
24848988	Association	MESH:D012183	351
24848988	Association	MESH:D000544	5581

